IDEAS home Printed from https://ideas.repec.org/a/dbk/health/v3y2024ip.543id.543.html
   My bibliography  Save this article

Preclinical evaluation of the anti-inflammatory activity of moringa oil

Author

Listed:
  • Sarmiento Tomalá
  • Burbano Gómez
  • Soledispa Cañarte
  • López Barrera
  • Valdiviezo Rogel
  • Jimenez Granizo

Abstract

The use of NSAIDs has a maximum ceiling effect, the dose increase does not improve the therapeutic activity, but it increases the adverse effects; Irrational, continuous, and prolonged use produces toxic reactions. The purpose of this research is to present a natural alternative (oil of Moringa oleifera); in which the anti-inflammatory activity property attributed to the fatty acids present in the chemical composition was evaluated. So we have: Omega 3 (89.21%), Omega 6 (11.90%) being these which participate in the process of anti-inflammation. Five groups of seven albino mice OF-01 each, were made. With the help of a micropipette the phlebogen agent (2% croto oil) was applied to the right ear, causing inflammation (edema). Then, the different treatments were placed: Group (A) negative control without treatment with inflammation, (B) positive control (diclofenac), groups (C, D, E) treated with the oil in volume (ul): 20 , 40, 60 respectively. After four hours euthanasia was given to animals, the ears were cut and a 6 mm diameter disc was obtained from each one (right and left ear), finally these were weighed. At the end of the study the following average weights of the ears were obtained (right): (A) 12.49 ± 2.73; (B) 9.56 ± 3.19; (C) 9.41 ± 1.52; (D) 8.61 ± 1.27; (E) 8.86 ± 1.73. Average percentages of inflammation: (A) 96.65 ± 5.10; (B) 61.33 ± 17.30; (C) 60.69 ± 8.64; (D) 28.64 ± 13.38; (E) 34.15 ± 11.37.The percentage of inhibition (A) 0, (B) (36.54%), (C) (37.21%), (D) (70.36%), (E) (64.66%). There was a significant difference p

Suggested Citation

Handle: RePEc:dbk:health:v:3:y:2024:i::p:.543:id:.543
DOI: 10.56294/hl2024.543
as

Download full text from publisher

To our knowledge, this item is not available for download. To find whether it is available, there are three options:
1. Check below whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a
for a similarly titled item that would be available.

More about this item

Statistics

Access and download statistics

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:dbk:health:v:3:y:2024:i::p:.543:id:.543. See general information about how to correct material in RePEc.

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

We have no bibliographic references for this item. You can help adding them by using this form .

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Javier Gonzalez-Argote (email available below). General contact details of provider: https://hl.ageditor.ar/ .

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.